Skip to main content
. 2012 Apr 5;2(4):363–373. doi: 10.7150/thno.3724

Figure 2.

Figure 2

Patterns of infection, replication and biodistribution and persistence within the tumor after intravenous delivery of oncolytic vaccinia (vvDD) expressing luciferase as determined by bioluminescence imaging on an IVIS200 (Xenogen, part of Caliper, now part of Perkin Elmer)